A randomized, double-blind trial evaluating the efficacy...

  • Main
  • 2017 / 10
  • A randomized, double-blind trial evaluating the efficacy...

A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes

Home, Philip, Ravi Shankar, R., Gantz, Ira, Iredale, Carol, O'Neill, Edward A., Jain, Lokesh, Pong, Annpey, Suryawanshi, Shailaja, Engel, Samuel S., Kaufman, Keith D., Lai, Eseng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes Research and Clinical Practice
DOI:
10.1016/j.diabres.2017.10.018
Date:
October, 2017
File:
PDF, 993 KB
english, 2017
Conversion to is in progress
Conversion to is failed